Porvair to produce materials for filtration and diffusion

Published: 12-Mar-2010
Packaging

BioVyon polymer materials are aimed at pharmaceutical and biotech companies

Porvair Filtration Group in the UK has developed a highly purified porous polymeric material called BioVyon to complement contract manufacturing for the life science market. Chemically modified using novel technologies, the materials are aimed at pharmaceutical, biotech, healthcare and analytical companies for filtration, separation, purification, diffusion and fluid transfer applications.

BioVyon materials are primarily made from polyethylene or polypropylene sintered porous plastic, made by proprietary cGMP processes with low extractable and particle shedding levels. Available in pore sizes from 5 to 100 micron (mean flow pore) the materials are available in sheet, roll, cut shapes or moulded and, depending on the particular specification, have regulatory approvals that meet FDA, WDA and USP requirements.

Porvair Filtration Group has opened a Class 100000 (ISO Class 8) cleanroom at its Wrexham, UK site to produce and package regulatory controlled materials and assembled products in a clean environment.

An ISO 9001-2000 quality assurance programme, cGMP practices and cleanroom environment to ensure products meet the stringent requirements of the life science industries, underpins the manufacture of these specialist high performance products.

See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Cloud labelling and serialisation: the new frontline of traceability in drug delivery

Read more
As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence

Trending Articles

  1. ProMach Pharma presents new equipment at Pack Expo Las Vegas Several new systems will be on exhibit for the first time, alongside other advanced processing and packaging equipment for pharmaceuticals, biopharmaceuticals, nutraceuticals, medical devices and more
  2. Aenova Group In Europe and worldwide, Aenova is one of the leading contract development and manufacturing organisations (CDMO). The range of services covers the entire value chain of development and production of all common dosage forms (solid, semi-solid and liquid, sterile and non-sterile; high potency and low dosage) and product groups in drugs and food supplements for human and animal health
  3. Intranasal GLP-1 medication from Orexo shows positive results in preclinical trial Orexo's AmorphOX technology had positive results when compared against oral and injectable formulations in the study
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    From approval to access: the strategic role of packaging in drug launch success In today’s increasingly complex pharmaceutical landscape, securing regulatory approval is only one milestone on the journey to market
  5. SGD Pharma acquires Alphial Srl in a strategic step forward SGD Pharma is pleased to announce an agreement with Italian Private Equity firm Entangled Capital to acquire Alphial Srl, a leading producer of tubular vials and ampoules headquartered in Italy

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Cloud labelling and serialisation: the new frontline of traceability in drug delivery

As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
Packaging

ProMach Pharma presents new equipment at Pack Expo Las Vegas

Several new systems will be on exhibit for the first time, alongside other advanced processing and packaging equipment for pharmaceuticals, biopharmaceuticals, nutraceuticals, medical devices and more
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

From approval to access: the strategic role of packaging in drug launch success

In today’s increasingly complex pharmaceutical landscape, securing regulatory approval is only one milestone on the journey to market
Packaging

Intranasal GLP-1 medication from Orexo shows positive results in preclinical trial

Orexo's AmorphOX technology had positive results when compared against oral and injectable formulations in the study
Packaging

SGD Pharma acquires Alphial Srl in a strategic step forward

SGD Pharma is pleased to announce an agreement with Italian Private Equity firm Entangled Capital to acquire Alphial Srl, a leading producer of tubular vials and ampoules headquartered in Italy
Packaging

Smart RFID labels from Schreiner MediPharm: safety and efficiency in the healthcare sector

The Robust RFID labels from Schreiner MediPharm enable the precise tracking of drugs, reduce medication errors and enhance supply efficiency
Packaging

SCHOTT Pharma launches ready-to-use polymer cartridge

Rising demand for sensitive biologics and patient-friendly administration calls for new drug delivery solutions
Subscribe now